Suppliers / Corden Pharma Bergamo

Corden Pharma Bergamo

Italy 2 duplicate records merged Updated 9 July 2026

The public registers hold a second record for Corden Pharma Bergamo. The fuller profile, with 17 active US DMFs and 3 valid CEPs, is at Corden Pharma. Figures on this page cover only this record.

Corden Pharma Bergamo is an API manufacturer based in Italy. It holds 4 active US drug master files and 2 valid CEPs across a filed portfolio of 4 molecules. Its most recent recorded inspection, by US FDA, closed on 18 March 2022 as VAI.

4
active US DMFs
2
valid CEPs
2
registered plants 1 with an FDA FEI number
1
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
4 of 4 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 18 March 2022 VAI US FDA
  • 27 September 2018 VAI US FDA
  • 17 June 2016 VAI US FDA
  • 8 November 2013 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Treviglio, Italy Not on file
Italy, Italy 3002806963

What they file, and where

Molecule Regulators Docs
Metronidazole EDQM, US FDA 3
Benzoyl Peroxide SFDA (Saudi Arabia), US FDA 2
Disulfiram US FDA 1
Secnidazole US FDA 1

Also appears on these molecule pages

Benzoyl Peroxide API Metronidazole API

Filings and GMP by regulator

Regulator Filings GMP certificates
MINSA (CR) 1 None

Questions about Corden Pharma Bergamo

Does Corden Pharma Bergamo hold a US DMF or a CEP?
Corden Pharma Bergamo holds 4 active US drug master files and 2 valid CEPs. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Is Corden Pharma Bergamo FDA-registered?
One site operated by Corden Pharma Bergamo carries an FDA establishment identifier (FEI), which means it is registered with the FDA as a drug establishment. Registration is not the same as approval or inspection clearance.
How did Corden Pharma Bergamo's last inspection go?
The most recent inspection on record closed on 18 March 2022 as VAI (Voluntary Action Indicated: issues were found but did not warrant regulatory action). 4 inspections are on file.
Where does Corden Pharma Bergamo manufacture?
2 registered sites are on record, in Italy (Treviglio and Italy). Every site is listed on this page with the register it came from.
What does Corden Pharma Bergamo make?
4 molecules are on record against Corden Pharma Bergamo, including Metronidazole, Benzoyl Peroxide, Disulfiram and Secnidazole. Each links through to that molecule's full manufacturer list.
Where does Corden Pharma Bergamo file?
Filings are on record with MINSA (CR), 1 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Corden Pharma Bergamo comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 18 March 2022.

Comparable suppliers

Zydus Lifesciences shares 1 molecule Unichem Laboratories shares 1 molecule Cambrex Karlskoga AB shares 1 molecule Wuhan Wuyao Pharmaceutical shares 1 molecule Bajaj Healthcare shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability